Help us revolutionize the way drugs are discovered & developed
Founded by scientists from the world’s leading neurogenomics labs, we are building the next-generation biopharmaceutical company using a data-driven model of drug discovery. We are looking for passionate, motivated scientists to help us tackle our generation’s biggest healthcare challenges: Alzheimer’s Disease, ALS, and Parkinson’s Disease. Verge’s genomic network approach offers a breakthrough opportunity to identify drugs that improve patient outcomes and fundamentally bend the cost curve of drug discovery and development.
We are backed by some of the top funders in Silicon Valley and New York, including IA Ventures, Two Sigma, Draper Associates, Slow Ventures, and YCombinator (S15).